File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Article: Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria

TitleGold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
Authors
KeywordsAntimicrobial resistance
Colistin
Combination therapy
Gold
MCR-1
Issue Date20-Jan-2023
PublisherSpringer
Citation
Journal of Biological Inorganic Chemistry, 2023, v. 28, n. 2, p. 225-234 How to Cite?
Abstract

The emergence and rapid spread of the mobile colistin resistance gene mcr-1 among bacterial species and hosts significantly challenge the efficacy of "last-line" antibiotic colistin. Previously, we reported silver nitrate and auranofin serve as colistin adjuvants for combating mcr-1-positive bacteria. Herein, we uncovered more gold-based drugs and nanoparticles, and found that they exhibited varying degree of synergisms with colistin on killing mcr-1-positive bacteria. However, pre-activation of the drugs by either glutathione or N-acetyl cysteine, thus releasing and accumulating gold ions, is perquisite for their abilities to substitute zinc cofactor from MCR-1 enzyme. X-ray crystallography and biophysical studies further supported the proposed mechanism. This study not only provides basis for combining gold-based drugs and colistin for combating mcr-1-positive bacterial infections, but also undoubtedly opens a new horizon for metabolism details of gold-based drugs in overcoming antimicrobial resistance.


Persistent Identifierhttp://hdl.handle.net/10722/337970
ISSN
2023 Impact Factor: 2.7
2023 SCImago Journal Rankings: 0.543
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhang, Qi-
dc.contributor.authorWang, Minji-
dc.contributor.authorHu, Xuqiao-
dc.contributor.authorYan, Aixin-
dc.contributor.authorHo, Pak-Leung-
dc.contributor.authorLi, Hongyan-
dc.contributor.authorSun, Hongzhe-
dc.date.accessioned2024-03-11T10:25:17Z-
dc.date.available2024-03-11T10:25:17Z-
dc.date.issued2023-01-20-
dc.identifier.citationJournal of Biological Inorganic Chemistry, 2023, v. 28, n. 2, p. 225-234-
dc.identifier.issn0949-8257-
dc.identifier.urihttp://hdl.handle.net/10722/337970-
dc.description.abstract<p>The emergence and rapid spread of the mobile colistin resistance gene mcr-1 among bacterial species and hosts significantly challenge the efficacy of "last-line" antibiotic colistin. Previously, we reported silver nitrate and auranofin serve as colistin adjuvants for combating mcr-1-positive bacteria. Herein, we uncovered more gold-based drugs and nanoparticles, and found that they exhibited varying degree of synergisms with colistin on killing mcr-1-positive bacteria. However, pre-activation of the drugs by either glutathione or N-acetyl cysteine, thus releasing and accumulating gold ions, is perquisite for their abilities to substitute zinc cofactor from MCR-1 enzyme. X-ray crystallography and biophysical studies further supported the proposed mechanism. This study not only provides basis for combining gold-based drugs and colistin for combating mcr-1-positive bacterial infections, but also undoubtedly opens a new horizon for metabolism details of gold-based drugs in overcoming antimicrobial resistance.<br></p>-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofJournal of Biological Inorganic Chemistry-
dc.subjectAntimicrobial resistance-
dc.subjectColistin-
dc.subjectCombination therapy-
dc.subjectGold-
dc.subjectMCR-1-
dc.titleGold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria-
dc.typeArticle-
dc.identifier.doi10.1007/s00775-022-01983-y-
dc.identifier.scopuseid_2-s2.0-85146590678-
dc.identifier.volume28-
dc.identifier.issue2-
dc.identifier.spage225-
dc.identifier.epage234-
dc.identifier.eissn1432-1327-
dc.identifier.isiWOS:000920395100001-
dc.identifier.issnl0949-8257-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats